Skip to main content
OpenTrials

Clinical trial condition

Graves Disease

Explore clinical trials studying Graves Disease. Study availability and eligibility vary by location and protocol.

125 public trials 38 recruiting studies
Refine in advanced search Browse all conditions

Graves Disease trial results

Completed

An Open-label Study (OLE) for Non-responders of VRDN-001-101 and VRDN-001-301

NCT06179875

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Advancing Research International, LLC Los Angeles, California, United States
  • USC Eye Institute Los Angeles, California, United States
  • Advancing Research International, LLC Newport Beach, California, United States
  • Stanford Byers Eye Institute Palo Alto, California, United States
View all 45 locations
View Trial Details
Completed

A Safety, Tolerability, and Efficacy Study of Veligrotug (VRDN 001) in Participants With Thyroid Eye Disease (TED)

NCT05176639

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • University of Colorado - Department of Ophthalmology Aurora, California, United States
  • The Private Office of Raymond Douglas Beverly Hills, California, United States
  • USC Roski Eye Institute Los Angeles, California, United States
  • MACRO Trials, Inc. Los Angeles, California, United States
View all 53 locations
View Trial Details
Completed

A Randomized, Controlled, Safety and Tolerability Study of VRDN-001 in Participants With Thyroid Eye Disease (TED)

NCT06384547

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • United Medical Research Institute Inglewood, California, United States
  • Advancing Research International, LLC Los Angeles, California, United States
  • Stanford Byers Eye Institute Palo Alto, California, United States
  • Cockerham Eye Consultants, PC San Diego, California, United States
View all 50 locations
View Trial Details
Completed

An Efficacy, Safety, and Tolerability Study of Veligrotug (VRDN-001), in Participants With Chronic Thyroid Eye Disease (TED)

NCT06021054

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Advancing Research International, LLC Los Angeles, California, United States
  • USC Roski Eye Institute Los Angeles, California, United States
  • Amy Patel Jain, MD Newport Beach, California, United States
  • Stanford Byers Eye Institute Palo Alto, California, United States
View all 57 locations
View Trial Details
Completed

Selenium Supplementation Versus Placebo in Patients With Graves' Hyperthyroidism

NCT01611896

Conditions
Autoimmune Diseases, Endocrine System Diseases, Exophthalmos, +8 more
Locations
  • Department of Endocrinology and Gastroenterology, Bispebjerg Hospital Copenhagen, Denmark
  • Department of Medical Endocrinology, Rigshospitalet Copenhagen, Denmark
  • Department of Endocrinology, Hospital of Southwest Denmark Esbjerg, Denmark
  • Department of Medicine, Gentofte Hospital Gentofte Municipality, Denmark
View Trial Details

Related conditions